Medtronic 2016 Annual Report Download - page 5

Table of Contents
2
Diabetes Group (Fiscal year 2016 net sales of $1.9 billion)
• Intensive Insulin Management
• Non-Intensive Diabetes Therapies
• Diabetes Service & Solutions
CARDIAC AND VASCULAR GROUP
Cardiac Rhythm & Heart Failure Disease Management (CRHF)
Our CRHF division develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm
disorders and heart failure. Our products include implantable devices, leads and delivery systems, products for the treatment of
atrial fibrillation (AF), products designed to reduce surgical site infections, information systems for the management of patients
with CRHF devices, and an integrated health solutions business.
The following are the principal products and services offered by our CRHF division:
Implantable Cardiac Pacemakers (Pacemakers) Our latest generations of pacemaker systems are the Advisa MRI SureScan
models, the Micra Transcatheter Pacing System, and the Ensura MRI SureScan model. The Micra Transcatheter Pacing System,
which is leadless and does not have a subcutaneous device pocket like conventional pacemaker, and the Advisa MRI SureScan
models have received United States (U.S.) Food and Drug Administration (U.S. FDA) approval and Conformité Européene (CE)
Mark approval, while the Ensura MRI SureScan models have received CE Mark approval.
Implantable Cardioverter Defibrillators (ICDs) Our latest generation ICD is the Evera MRI SureScan, the first ICD system with
CE Mark, PMDA (Japan), and U.S. FDA, approval for full-body MRI scans for both 1.5T and 3T scanners. The Evera system is
paired with the reliable Sprint Quattro Secure lead, the only defibrillator lead with more than 11 years of proven performance with
active monitoring.
Implantable Cardiac Resynchronization Therapy Devices (CRT-Ds and CRT-Ps) Our latest generation of CRT-Ds is the Amplia/
Compia/Claria family of MRI Quad CRT-D SureScan systems. The U.S. FDA and CE Mark approved Amplia and Compia MRI
Quad CRT-D SureScan systems are approved for MRI scans on any part of the body. In addition, the Viva/Brava family with Attain
Performa quadripolar features a new algorithm, called AdaptivCRT, which improves heart failure patients' response rate to CRT-
D therapy. Viva CRT-P is our latest generation device, with respect to CRT-P.
AF Products Our portfolio of AF products includes the Arctic Front Advance Cardiac Cryoballoon System, which includes the
U.S. FDA approved Aortic Front Advance ST Cryoablation Catheter, designed for pulmonary vein isolation in the treatment of
patients with drug refractory paroxysmal AF. Additionally, we have a second-generation CE Mark approved Phased RF System,
PVAC Gold, which uses duty cycled, phased radio frequency energy for the treatment of symptomatic paroxysmal persistent and
long-standing persistent AF.
Diagnostics and Monitoring Devices Our Reveal LINQ is our newest Insertable Cardiac Monitor (ICM) System. The system is
used to record the heart’s electrical activity before, during, and after transient symptoms such as syncope (i.e., fainting) and
palpitations to assist in diagnosis.
TYRX Products Our TYRX products include the Absorbable Antibacterial Envelope and the TYRX Neuro Absorbable
Antibacterial Envelope, which are designed to stabilize electronic implantable devices and help prevent infection associated with
implantable pacemakers, defibrillators, and spinal cord neurostimulators.
Services and Solutions Our Care Management Services products and services include remote monitoring and patient-centered
software to enable efficient care coordination and specialized telehealth nurse support. Our Cath Lab Managed Services business
is focused on developing novel partnerships with hospitals to provide services directly related to hospital operational efficiency.
Coronary & Structural Heart Disease Management (CSH)
Our CSH division includes therapies to treat coronary artery disease (CAD), and heart valve disorders. Our products include
coronary stents and related delivery systems, including a broad line of balloon angioplasty catheters, guide catheters, guide wires,
diagnostic catheters, and accessories as well as products for the repair and replacement of heart valves, perfusion systems,
positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products.
The following are the principal products offered by our CSH division:
Transcatheter Heart Valves (TCVs) Our latest generation TCVs include the CoreValve family of aortic valves. CoreValve, which
is the only TCV system shown to be superior to open-heart surgery, has received U.S. FDA approval for extreme and high risk